WuXi AppTec’s Post

dig even deeper to .. find the emerging science find the digital opinion leaders, HCPs, patient groups identitlfy rising digital stars build your digital communications trusted networks and of course set up ALERTS to make sure you know what is being talked about for the other 360 days a year AND understand the Sentiment.

Our latest Medsider playbook includes 5 lessons on how to efficiently navigate the regulatory landscape when developing novel #medicaldevices.   Key learnings from this playbook include: 🗺️ Map out your course by first building a focused prototype without excess complexity. 🤝 Ensure efficiency by engaging regulatory professionals from the start. ⚖️ Find balance by pairing regulatory boundary-pushers with conservative experts. 🗣️ Stay engaged through frequent and transparent dialogue with regulatory bodies. 🎓 Help regulators understand the nuances of your technology to fast-track approval. Read the full playbook (link in comments) to discover helpful lessons from the following #medtech founders and CEOs: ➡ Derek Herrera, CEO of Bright Uro ➡ Allison London Brown, CEO of LUMINELLE 360 ➡ Joe Landolina, CEO of Cresilon  ➡ Caroline J Loew, PhD, former CEO of Glympse Bio and current CEO of Mural Oncology  ➡ Sina Habibi, CEO of Cognetivity Neurosciences Ltd

Exciting to share the below webinar #CRALifeSciences is hosting in a couple of weeks' time on the evolving business models in digital therapeutics. See the link to learn more and register! #DigitalTherapeutics

Perfect timing for our webinar coming up next week April 24th. ⌚ Just days away from the news that Click Therapeutics and Otsuka secured FDA clearance for the first prescription digital program designed for adults with major depressive disorder (#MDD) Charles River Associates is holding a webinar on #digitaltherapeutics with the participation of Click Therapeutics, Inc. and DarioHealth Join to understand the challenges, the success factors and the latest trends on business models in #digitalhealth

In our last post, we explored conference engagement, uncovering the most active participants. But what were they saying? We honed in on one condition area (NASH) and delved even deeper by looking specifically at the outcome fibrosis. The results are interesting 🔎 Some of the most active contributors to the conversation about NASH were smaller biotech companies rather than the giants of Big Pharma. This serves as a testament to the increasing influence of innovation and smaller players in the healthcare landscape. So, what's the verdict? Conference dynamics are evolving. It's time to pay attention to the entire market because it's no longer just the major players who are attending, sharing their perspectives, and shaping science. Are you ready to enhance your digital presence at conferences? Contact us at https://www.visfo.health/ to learn how the VISFO team can empower your journey with data-driven insights. 🚀 #conferencelistening #digitalinsights #digitalmentions #pharmainsights

All these data points are invaluable on the journey to True Insights! As me how iGen and VISFO can help 💕 #medicalaffairs #medicalinsights #strategicinsights #igen

#digitalhealth attracted huge amounts of investment over the last several years. Recently there has been a shakeout of early entrants and a sharper focus on investment thesis. Want to know what’s next? Tune in to hear @Gil Bashe and other experts opine on what to watch in the future in this @Galen Growth webinar.

Loving the energy at the Swiss BioTech Day! I am still excited from the great connections and fascinating scientific discussions I had! Here are my key takeaways: ⭐Innovation & Regulation: Swissmedic and ANVISA panel showed the importance of involving regulatory bodies early in the innovation process. It's crucial for ensuring that groundbreaking ideas gain acceptance from regulators. ⭐Public Communication: communicate innovations to the general public is often overlooked but it is key. Clear explanations can drive and accelerate market adoption. ⭐Investment in Innovation: Innovators and investors must understand each other. A clear pitch deck and a solid go-to-market strategy can significantly speed up decision-making. A huge shoutout to Daniela Marino from CUTISS AG for showcasing groundbreaking science in personalized skin technology. DenovoSkin is set to transform the treatment of large skin injuries, revolutionizing burn recovery. #SwissBioTechDay #Innovation #Science #Networking 

This Wednesday is setting up not to be your average run-of-the-mill hump day in #digitalhealth and #digitaltherapeutics. Steven Wardell’s DigitalHealth InvestorTalk will dive into the digital health solutions #supplychain and the aggregators, navigators, care coordinators and value-added service providers creating preferred marketplaces of the 10’s to 100’s of thousands of #virtualcare and #digitaltherapeutics offerings. This is a 1st and we’re delighted to join the conversation. #employeebenefits #employeehealth #employees #health #wellbeing #healthcare #healthcarebenefits #selfcare #humancapital #humanresources #people #DTx #remotepatientmonitoring #prevention #medicaldevices #digital #medicine #pbms #pharmacybenefits #medical #benefits #RTM #RPM #artificialintelligence #machinelearning #SaMD